Divakaran, Anand
37  results:
Search for persons X
?
3

Development of an N-Terminal BRD4 Bromodomain-Targeted Degr..:

Divakaran, Anand ; Scholtz, Cole R. ; Zahid, Huda...
ACS Medicinal Chemistry Letters.  13 (2022)  10 - p. 1621-1627 , 2022
 
?
 
?
5

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford P..:

Cui, Huarui ; Carlson, Angela S. ; Schleiff, Mary A....
Journal of Medicinal Chemistry.  64 (2021)  14 - p. 10497-10511 , 2021
 
?
7

Selective N‐Terminal BET Bromodomain Inhibitors by Targetin..:

Cui, Huarui ; Divakaran, Anand ; Pandey, Anil K....
Angewandte Chemie International Edition.  60 (2020)  3 - p. 1220-1226 , 2020
 
?
9

SAR by (Protein-Observed) 19F NMR:

Divakaran, Anand ; Kirberger, Steven E. ; Pomerantz, William C. K.
Accounts of Chemical Research.  52 (2019)  12 - p. 3407-3418 , 2019
 
?
10

Systematically Mitigating the p38α Activity of Triazole-bas..:

Carlson, Angela S. ; Cui, Huarui ; Divakaran, Anand...
ACS Medicinal Chemistry Letters.  10 (2019)  9 - p. 1296-1301 , 2019
 
?
11

Molecular Basis for the N-Terminal Bromodomain-and-Extra-Te..:

Divakaran, Anand ; Talluri, Siva K. ; Ayoub, Alex M....
Journal of Medicinal Chemistry.  61 (2018)  20 - p. 9316-9334 , 2018
 
?
 
1-15